s20098 has been researched along with malondialdehyde in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gupta, S; Sharma, B; Sharma, BM; Singh, P | 1 |
Copoglu, US; Dokuyucu, R; Erbas, O; Inanir, A; Inanir, S; Kokacya, H | 1 |
Alper, F; Bayraktutan, Z; Diyarbakir, B; Durur-Karakaya, A; Durur-Subasi, I; Gundogdu, C; Karaman, A; Kose, D; Özbek-Bilgin, A; Topcu, A | 1 |
Ateş, U; Başol, N; Çavuşoğlu, T; Erbaş, O; Meral, A | 1 |
Yao, K; Zhao, YF; Zu, HB | 1 |
5 other study(ies) available for s20098 and malondialdehyde
Article | Year |
---|---|
Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia.
Topics: Acetamides; Acetylcholinesterase; Analysis of Variance; Animals; Arterial Occlusive Diseases; Brain; Catalase; Dementia, Vascular; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Male; Malondialdehyde; Maze Learning; Mice; Neuroprotective Agents; Superoxide Dismutase; Time Factors; Vinca Alkaloids | 2015 |
Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model.
Topics: Acetamides; Animals; Brain; Lipopolysaccharides; Male; Malondialdehyde; Melatonin; Psychotic Disorders; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2015 |
A novel approach to contrast-induced nephrotoxicity: the melatonergic agent agomelatine.
Topics: Acetamides; Animals; Contrast Media; Cytokines; Disease Models, Animal; Female; Glutathione; Interleukin-6; Kidney; Malondialdehyde; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Selective Serotonin Reuptake Inhibitors; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |
Beneficial effects of agomelatine in experimental model of sepsis-related acute kidney injury.
Topics: Acetamides; Acute Kidney Injury; Animals; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Hypnotics and Sedatives; Injections, Intraperitoneal; Male; Malondialdehyde; Models, Animal; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2016 |
Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells.
Topics: Acetamides; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antidepressive Agents; Cell Survival; Malondialdehyde; Oxidative Stress; PC12 Cells; Peptide Fragments; Phosphorylation; Rats; Receptors, Melatonin; tau Proteins; Tryptamines | 2019 |